Literature DB >> 24463567

MIF, a potential therapeutic target for rheumatoid arthritis?

Zhaolin Chen1, Taotao Ma, Cheng Huang, Lei Zhang, Tingting Hu, Jun Li.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24463567     DOI： 10.1007/s00296-013-2877-y

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN： 0172-8172            Impact factor:   2.631


× No keyword cloud information.
  11 in total

1.  Influence of MIF, CD40, and CD226 polymorphisms on risk of rheumatoid arthritis.

Authors:  Ruiping Liu; Nanwei Xu; Xinxiang Wang; Li Shen; Gongyin Zhao; Hui Zhang; Weimin Fan
Journal:  Mol Biol Rep       Date:  2012-06       Impact factor: 2.316

2.  Macrophage migration inhibitory factor up-regulates matrix metalloproteinase-9 and -13 in rat osteoblasts. Relevance to intracellular signaling pathways.

Authors:  Shin Onodera; Jun Nishihira; Kazuya Iwabuchi; Yoshikazu Koyama; Kazuhiko Yoshida; Sakae Tanaka; Akio Minami
Journal:  J Biol Chem       Date:  2001-12-20       Impact factor: 5.157

3.  Macrophage migration inhibitory factor up-regulates expression of matrix metalloproteinases in synovial fibroblasts of rheumatoid arthritis.

Authors:  S Onodera; K Kaneda; Y Mizue; Y Koyama; M Fujinaga; J Nishihira
Journal:  J Biol Chem       Date:  2000-01-07       Impact factor: 5.157

4.  Serum levels of macrophage migration inhibitory factor are associated with rheumatoid arthritis course.

Authors:  Mara Anaís Llamas-Covarrubias; Yeminia Valle; Rosa Elena Navarro-Hernández; Iris Paola Guzmán-Guzmán; María Guadalupe Ramírez-Dueñas; Héctor Rangel-Villalobos; Ciro Estrada-Chávez; José Francisco Muñoz-Valle
Journal:  Rheumatol Int       Date:  2011-05-24       Impact factor: 2.631

5.  Elevated serum levels of macrophage migration inhibitory factor and their significant correlation with rheumatoid vasculitis disease activity.

Authors:  Kuninobu Wakabayashi; Kumiko Otsuka; Michihito Sato; Ryo Takahashi; Tsuyoshi Odai; Takeo Isozaki; Nobuyuki Yajima; Yusuke Miwa; Tsuyoshi Kasama
Journal:  Mod Rheumatol       Date:  2011-05-24       Impact factor: 3.023

6.  High expression of macrophage migration inhibitory factor in the synovial tissues of rheumatoid joints.

Authors:  S Onodera; H Tanji; K Suzuki; K Kaneda; Y Mizue; A Sagawa; J Nishihira
Journal:  Cytokine       Date:  1999-02       Impact factor: 3.861

7.  Macrophage migration inhibitory factor in patients with juvenile idiopathic arthritis.

Authors:  Cristina Meazza; Paola Travaglino; Patrizia Pignatti; Silvia Magni-Manzoni; Angelo Ravelli; Alberto Martini; Fabrizio De Benedetti
Journal:  Arthritis Rheum       Date:  2002-01

8.  Macrophage migration inhibitory factor (MIF): genetic evidence for participation in early onset and early stage rheumatoid arthritis.

Authors:  M A Llamas-Covarrubias; Y Valle; R Bucala; R E Navarro-Hernández; C A Palafox-Sánchez; J R Padilla-Gutiérrez; I Parra-Rojas; A G Bernard-Medina; Z Reyes-Castillo; J F Muñoz-Valle
Journal:  Cytokine       Date:  2013-02-09       Impact factor: 3.861

9.  Macrophage-derived, macrophage migration inhibitory factor (MIF) is necessary to induce disease in the K/BxN serum-induced model of arthritis.

Authors:  Anjana Singh; Lin Leng; Juan Fan; Mieczyslaw Gajda; Rolf Bräuer; Günter Fingerle-Rowson; Richard Bucala; Harald Illges
Journal:  Rheumatol Int       Date:  2013-03-17       Impact factor: 2.631

10.  Macrophage migration inhibitory factor enhances osteoclastogenesis through upregulation of RANKL expression from fibroblast-like synoviocytes in patients with rheumatoid arthritis.

Authors:  Hae-Rim Kim; Kyoung-Woon Kim; Hong Geun Jung; Kwang-Sup Yoon; Hye-Jwa Oh; Mi-La Cho; Sang-Heon Lee
Journal:  Arthritis Res Ther       Date:  2011-03-14       Impact factor: 5.156
View more
  2 in total

1.  Macrophage Migration Inhibitory Factor (MIF) Supports Homing of Osteoclast Precursors to Peripheral Osteolytic Lesions.

Authors:  Alexandru Movila; Takenobu Ishii; Abdullah Albassam; Wichaya Wisitrasameewong; Mohammed Howait; Tsuguno Yamaguchi; Montserrat Ruiz-Torruella; Laila Bahammam; Kazuaki Nishimura; Thomas Van Dyke; Toshihisa Kawai
Journal:  J Bone Miner Res       Date:  2016-06-02       Impact factor: 6.741

Review 2.  K/BxN Serum-Transfer Arthritis as a Model for Human Inflammatory Arthritis.

Authors:  Anne D Christensen; Claus Haase; Andrew D Cook; John A Hamilton
Journal:  Front Immunol       Date:  2016-06-02       Impact factor: 7.561
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.